Literature DB >> 3967850

Hepatitis B virus DNA in serum from patients with acute hepatitis B.

K Krogsgaard, P Kryger, J Aldershvile, P Andersson, C Brechot.   

Abstract

Sera from 77 consecutive patients with acute type B hepatitis were examined for hepatitis B virus DNA (HBV DNA) by a spot hybridization method. The median follow-up time was 8 months (range, 1 week to 3 years). HBV DNA was detected in 26 (34%) patients on admission to the hospital. A significant positive correlation was found between short duration of symptoms and the presence of HBV DNA (p less than 0.025). Twenty-four (46%) of 52 HBeAg-positive patients were HBV DNA positive compared to 2 HBV DNA-positive patients of 25 HBeAg-negative patients (8%) (p less than 0.001). Four HBeAg-negative patients had serum HBV DNA initially or during follow-up; three had anti-HBe. Six of 77 patients with acute type B hepatitis (8%) became chronic HBsAg carriers, and HBV DNA was detectable from 5 months to more than 3 years after onset of symptoms. The presence of serum HBV DNA for more than 8 weeks after initial symptoms may predict development of a chronic HBsAg carrier state. In none of the chronic carriers was serum HBV DNA present after clearing of HBeAg.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3967850     DOI: 10.1002/hep.1840050104

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions.

Authors:  Yi-Min Zhang; Yi-Da Yang; Hong-Yu Jia; Lin-Yan Zeng; Wei Yu; Ning Zhou; Lan-Juan Li
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels.

Authors:  Doan Y Dao; Linda S Hynan; He-Jun Yuan; Corron Sanders; Jody Balko; Nahid Attar; Anna S F Lok; R Ann Word; William M Lee
Journal:  Hepatology       Date:  2012-01-31       Impact factor: 17.425

3.  Pattern and duration of HBV DNA seropositivity in acute hepatitis B.

Authors:  J R Wood; H F Taswell; A J Czaja; D Rabe
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

Review 4.  Viral markers in the treatment of hepatitis B and C.

Authors:  H Schmilovitz-Weiss; M Levy; N Thompson; G Dusheiko
Journal:  Gut       Date:  1993       Impact factor: 23.059

5.  The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation.

Authors:  H J Schlicht; J Salfeld; H Schaller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  Assay of hepatitis B virus genome titers in sera of infected subjects.

Authors:  E Zyzik; W H Gerlich; A Uy; H Köchel; R Thomssen
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

7.  Quantitative detection of hepatitis B virus DNA in sera from patients with acute hepatitis B.

Authors:  N C Tassopoulos; M C Kuhns; M G Koutelou; A L McNamara; A Todoulos
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

8.  Infectivity of medical staff for hepatitis B.

Authors:  H Hofmann; W Tuma; F X Heinz; W Frisch-Niggemeyer; C Kunz
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

9.  Chronic evolution of acute hepatitis type B: prevalence and predictive markers.

Authors:  F Bortolotti; A Bertaggia; C Crivellaro; M Armigliato; A Alberti; P Pontisso; C Chemello; G Realdi
Journal:  Infection       Date:  1986 Mar-Apr       Impact factor: 3.553

10.  Evaluation of the pre-S (pre-S(1)Ag/pre-S(2)Ab) system in hepatitis B virus infection.

Authors:  M I Galán; J Tomás; M C Bernal; F J Salmerón; M C Maroto
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.